Loading stock data…
Solventum Corporation (SOLV)
$78.24-1.29 (-1.62%)
After Hours$78.07-0.17 (-0.21%)· Last close Jun 29
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Solventum Corporation in the Healthcare sector is trading at $78.24 with a market capitalization of $13.2B. Wall Street consensus targets $82.15 (13 analysts), implying a +5.0% move over the next 12 months. The stock is currently 11% below its 52-week high of $88.20, remaining 5.0% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +5.0% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.01B↑ | $2.00B↓ | $2.10B↓ | $2.16B↑ | $2.07B |
| Gross Profit | $1.09B↑ | $1.03B↓ | $1.14B↓ | $1.18B↑ | $1.11B |
| Operating Income | $79.00M↓ | $93.00M↓ | $172.00M↓ | $214.00M↑ | $152.00M |
| Net Income | $13.00M↓ | $63.00M↓ | $1.27B↑ | $90.00M↓ | $137.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Den...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.19B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
28.81%
Volume
Today's trading volume
772,190
Recent News
3 Mid-Cap Stocks We Steer Clear Of
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
3 Healthcare Stocks with Questionable Fundamentals
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realized strong financial performance, and over the past six months, the industry’s 7.6% return has closely followed the S&P 500.
Solventum Stock: Is SOLV Underperforming the Healthcare Sector?
The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw.
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?
Cooper Companies has lagged behind the healthcare sector over the past year, and analysts remain moderately bullish about its prospects.
Solventum (SOLV) Stock Valuation Gap Examined After Recent Momentum Gains
Solventum (SOLV) has started to attract more attention after its recent trading performance, with the stock up about 6% over the past month and roughly 18% over the past three months. See our latest analysis for Solventum. Zooming out, Solventum’s share price is now at US$78.87, with a 1 day share price return slightly down at 0.44%, while the 1 month share price return of about 6% and 3 month share price return of roughly 18% suggest momentum has been building. This comes even as the year to...